The invention relates to a new monitoring and treatment device for obstructive sleep apnea syndrome (OSA).
It is the first Proof of concept identifying kinesthetic stimulation as a potentially effective therapy for OSA.
The sleep apnea medical devices market will reach 6.5B€ in 2023, with a 8% CAGR for therapeutic devices (representing more than 80% of the market).
The system is composed of 3 components:
- a cardio-respiratory recorder,
- a kinesthetic stimulator
- and a real-time processing application, integrating an “on-off” control method to trigger the kinesthetic stimulation as a function of respiratory event detection of a given patient.
Kinesthetic stimulation for obstructive sleep apnea syndrome: An “on-of” proof of concept trial
Alfredo I. Hernández, Diego Pérez, Delphine Feuerstein, Corinne Loiodice, Laurence Graindorge, Gustavo Guerrero, Nadège Limousin, Frédéric Gagnadoux, Yves Dauvilliers, Renaud Tamisier, Arnaud Prigent, Philippe Mabo, Amel Amblard, Lotfi Senhadji & Jean-Louis Pépin, Scientific Reports volume 8, Article number: 3092 (2018)
2 LTSI patents
7 LTSI patents in co-ownership with an industrial partner
UMR_S 1099 - LTSI
Laboratoire Traitement du Signal et de l'Image|IMPACT - Images and Models for the Planning and AssistanCe to surgery and Therapy
FR : FR1461377 - filed on the 11-24-2014
WO - EP,US